跳至主要内容
临床试验/ACTRN12623001242617
ACTRN12623001242617招募中Unknown

PROlonged versus Single dose in PEnicillin oral Challenge Testing in adult with reported penicillin allergy: A pilot randomized placebo-cOntrolled tRial - The PROSPECTOR Study

Austin Health0 个研究点目标入组 120 人开始时间: 2023年11月30日最近更新:

试验速览

阶段
Unknown
状态
招募中
发起方
Austin Health
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Diagnosis
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Adult patients referred to the outpatient allergy clinic or inpatient allergy service for a penicillin allergy history (i.e. amoxicillin or penicillin unspecified)
  • 2. Adult patients with an immune-mediated penicillin allergy history with either delayed phenotype (> 2 hours post dose) or unknown timing
  • 3. Tolerated first dose of an oral penicillin challenge
  • 4. Being challenged to the implicated penicillin. In setting of unknown penicillin, challenge either to penicillin VK or amoxicillin
  • 5. Willing and able to give consent
  • 6. Willing and able to undergo telehealth or in clinic review post challenge

排除标准

  • 1. Patient age is < 18 years;
  • 2. Any other illness that, in the investigator’s judgement, will substantially increase the risk associated with subject’s participation in this study
  • 3. Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis to beta-lactam
  • 4. Inpatients receiving concurrent beta-lactam antibiotic therapy

研究者

发起方
Austin Health

相似试验